L
Lawrence Y. Agodoa
Researcher at National Institutes of Health
Publications - 225
Citations - 35763
Lawrence Y. Agodoa is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Population & Transplantation. The author has an hindex of 83, co-authored 224 publications receiving 33028 citations. Previous affiliations of Lawrence Y. Agodoa include Johns Hopkins University & University of Michigan.
Papers
More filters
Journal ArticleDOI
Survival Disparity of African American Versus Non–African American Patients With ESRD Due to SLE
Robert Nee,Jorge Martinez-Osorio,Christina M. Yuan,Dustin J. Little,Maura A. Watson,Lawrence Y. Agodoa,Kevin C. Abbott +6 more
TL;DR: In this paper, the impact of age stratification, socioeconomic factors, and kidney transplantation on the disparity in patient survival among African American versus non-African American patients with LN-caused ESRD, compared with other causes was assessed.
Journal Article
Outcomes associated with recipient and donor hepatitis C serology status after kidney transplantation in the United States: analysis of the USRDS/UNOS database.
TL;DR: Analysis of the USRDS kidney transplant registry disclosed that use of hepatitis C virus-positive donor (DHCV+) kidneys was an independent risk factor for patient death after kidney transplantation when compared to use of DHCV- kidneys, and that death in recipients of DCHV+ kidneys occurred earlier than previously reported.
Journal ArticleDOI
Hospitalized avascular necrosis after renal transplantation in the United States.
Kevin C. Abbott,Kevin C. Abbott,Robert J. Oglesby,Robert J. Oglesby,Lawrence Y. Agodoa,Lawrence Y. Agodoa +5 more
TL;DR: Patients with allograft rejection, African American race, peritoneal dialysis and earlier date of transplant were at the highest risk of AVN, while diabetic recipients were at a decreased risk.
Journal ArticleDOI
Hospitalizations for total hip arthroplasty after renal transplantation in the United States.
TL;DR: Although repeat surgeries are common, total hip arthroplasty is well tolerated and is not associated with increased mortality in this population, in contrast to the general population.
Journal Article
African American Study of Kidney Disease and hypertension (AASK)--clinical trial update.
TL;DR: This report provides an update on the Institute's initiative on hypertensive kidney disease in African Americans and, specifically, on the clinical trial African American Study of Kidney Disease and Hypertension (AASK).